Lennox-Gastaut syndrome

References

1. ↵
   1. Gastaut H,
   2. Roger J,
   3. Soulayrol R,
   4. Tassinari CA,
   5. Régis H,
   6. Dravet C,
   7. et al.

   (1966) Childhood epileptic encephalopathy with diffuse slow spike-waves (otherwise known as “petit mal variant”) or Lennox syndrome. Epilepsia 7, 139–179.
2. ↵
   1. Proposal for revised classification of epilepsies and epileptic syndromes

   (1989) Commission on Classification and Terminology of the International League Against Epilepsy. Epilepsia 30, 389–399.
3. ↵
   1. Hancock EC,
   2. Cross HH

   (2009) Treatment of Lennox-Gastaut syndrome. Cochrane Database Syst Rev 3, CD003277.
4. ↵
   1. Glauser T,
   2. Kluger G,
   3. Sachdeo R,
   4. Krauss G,
   5. Perdomo C,
   6. Arroyo S

   (2008) Rufinamide for generalized seizures associated with Lennox-Gastaut syndrome. Neurology 70, 1950–1958.
5. ↵
   1. Michoulas A,
   2. Farrell K

   (2010) Medical management of Lennox-Gastaut syndrome. CNS Drugs 24, 363–374.
6. ↵
   1. Dulac O,
   2. N’Guyen T

   (1993) The Lennox-Gastaut syndrome. Epilepsia 34, Suppl 7, S7–S17.
7. ↵
   1. Deekollu D,
   2. Besag FM,
   3. Aylett SE

   (2005) Seizure-related injuries in a group of young people with epilepsy wearing protective helmets: incidence, types and circumstances. Seizure 14, 347–353.
8. ↵
   1. Oguni H,
   2. Hayashi K,
   3. Osawa M

   (1996) Long-term prognosis of Lennox-Gastaut syndrome. Epilepsia 37, 44–47.
9. ↵
   1. Trevathan E,
   2. Murphy CC,
   3. Yeargin-Allsopp M

   (1997) Prevalence and descriptive epidemiology of Lennox-Gastaut syndrome among Atlanta children. Epilepsia 38, 1283–1288.
10. ↵
    1. Ferlazzo E,
    2. Nikanorova M,
    3. Italiano D,
    4. Bureau M,
    5. Dravet C,
    6. Calarese T,
    7. et al.

    (2010) Lennox-Gastaut syndrome in adulthood: clinical and EEG features. Epilepsy Res 89, 271–277.
11. ↵
    1. Arzimanoglou A,
    2. French J,
    3. blume WT,
    4. Cross JH,
    5. Ernst JP,
    6. Feucht M,
    7. et al.

    (2009) Lennox-Gastaut syndrome: a consensus approach on diagnosis, assessment, management, and trial methodology. Lancet Neurol 8, 82–93.
12. ↵
    1. Chevrie JJ,
    2. Aicardi J

    (1972) Childhood epileptic encephalopathy with slow spike-wave. A statistical study of 80 cases. Epilepsia 13, 259–271.
13. ↵
    1. Goldsmith IL,
    2. Zupanc ML,
    3. Buchhalter JR

    (2000) Long-term seizure outcome in 74 patients with Lennox-Gastaut syndrome: effects of incorporating MRI head imaging in defining the cryptogenic subgrou. Epilepsia 41, 395–399.
14. ↵
    1. Niedermeyer E,
    2. Degen R

    1. Ohtahara S,
    2. Ohtsuka Y,
    3. Yoshinaga H,
    4. Oka E,
    5. Yoshinaga H,
    6. Sato M

    (1988) Lennox-Gastaut syndrome: Etiological considerations. in The Lennox-Gastaut syndrome, eds Niedermeyer E, Degen R (Alan R. Liss, Inc, New York (NY)), 47–63.
15. ↵
    1. Camfield P,
    2. Camfield C

    (2007) Long-term prognosis for symptomatic (secondarily) generalized epilepsies: a population-based study. Epilepsia 48, 1128–1132.
16. ↵
    1. Autry AR,
    2. Trevathan E,
    3. Van Naarden Braun K,
    4. Yeargin-Allsopp M

    (2010) Increased risk of death among children with Lennox-Gastaut syndrome and infantile spasms. J Child Neurol 25, 441–447.
17. ↵
    1. Markand ON

    (2003) Lennox-Gastaut syndrome (childhood epileptic encephalopathy). J Clin Neurophysiol 20, 426–441.
18. ↵
    1. Harkin LA,
    2. McMahon JM,
    3. Iona X,
    4. Dibbens L,
    5. Pelekanos JT,
    6. Zuberi SM,
    7. et al.

    (2007) The spectrum of SCNIArelated infantile epileptic encephalopathies. Brain 130, 843–852.
19. ↵
    1. Selmer KK,
    2. Lund C,
    3. Brandal K,
    4. Undlien dE,
    5. Brodtkorb E

    (2009) SCN1A mutation screening in adult patients with Lennox-Gastaut syndrome features. Epilepsia 50, 555–557.
20. ↵
    1. Van Rijckevorsel K

    (2008) Treatment of Lennox-Gastaut syndrome: overview and recent findings. Neuropsychiatr Dis Treat 4, 1001–1019.
21. ↵
    1. Dulac O,
    2. N’Guyen T

    (1993) The Lennox-Gastaut syndrome. Epilepsia 34, Suppl 7, S7–S17.
22. ↵
    1. Niedermeyer E

    (2002) Lennox-Gastaut syndrome. Clinical description and diagnosis. Adv Exp Med Biol 497, 61–75.
23. ↵
    1. Arzimanoglou A,
    2. French J,
    3. Blume WT,
    4. Cross JH,
    5. Ernst JP,
    6. Feucht M,
    7. et al.

    (2009) Lennox-Gastaut syndrome: a consensus approach on diagnosis, assessment, management, and trial methodology. Lancet Neurol 8, 82–93.
24. ↵
    1. Yagi K

    (1996) Evolution of Lennox-Gastaut syndrome: A long-term longitudinal study. Epilepsia 37, 48–51.
25. ↵
    1. Markand ON

    (2003) Lennox-Gastaut syndrome (childhood epileptic encephalopathy). J Clin Neurophysiol 20, 426–441.
26. ↵
    1. Doose H,
    2. Gerken H,
    3. Leonhardt R,
    4. Völzke E,
    5. Völz C

    (1970) Centrencephalic myoclonic-astatic petit mal. Neuropadiatrie 2, 59–78.
27. ↵
    1. Jan MM,
    2. Girvin JP

    (2004) Febrile seizures. Update and controversies. Neurosciences (Riyadh) 9, 235–242.
28. ↵
    1. Gallop K,
    2. Wild D,
    3. Verdian L,
    4. Kerr M,
    5. Jacoby A,
    6. Baker G,
    7. et al.

    (2010) Lennox-Gastaut syndrome (LGS): development of conceptual models of health-related quality of life (HRQL) for caregivers and children. Seizure 19, 23–30.
29. ↵
    1. Carmant L,
    2. Whiting S

    (2012) lennox-Gastaut syndrome: an update on treatment. Can J Neurol Sci 39, 702–711.
30. ↵
    1. VanStraten AF,
    2. Ng YT

    (2012) Update on the management of Lennox-Gastaut syndrome. Pediatr Neurol 47, 153–161.
31. ↵
    1. Wheless JW,
    2. Clarke DF,
    3. Carpenter D

    (2005) Treatment of pediatric epilepsy: expert opinion, 2005. J Child Neurol 20, S1–S56, quiz S59-S60.
32. ↵
    1. Wheless JW,
    2. Clarke DF,
    3. Arzimanoglou A,
    4. Carpenter D

    (2007) Treatment of pediatric epilepsy: European expert opinion, 2007. Epileptic Disord 9, 353–412.
33. ↵
    1. Jan MM,
    2. Shaabat AO

    (2000) Clobazam for the treatment of intractable childhood epilepsy. Saudi Med J 21, 622–624.
34. ↵
    1. Jan MM

    (2005) Clinical review of pediatric epilepsy. Neurosciences (Riyadh) 10, 255–264.
35. ↵
    1. Jan MM,
    2. Zuberi SA,
    3. Alsaihati BA

    (2009) Pregabalin: preliminary experience in intractable childhood epilepsy. Ped Neurol 40, 347–350.
36. ↵
    1. Wheless JW,
    2. Clarke DF,
    3. Carpenter D

    (2005) Treatment of pediatric epilepsy: expert opinion, 2005. J Child Neurol 20, Suppl 1, S1–S56.
37. ↵
    1. Montouris GD

    (2011) Rational approach to treatment options for Lennox-Gastaut syndrome. Epilepsia 52, 10–20.
38. ↵
    1. Jeavons P,
    2. Clark J,
    3. Maheshwari M

    (1977) Treatment of generalized epilepsies of childhood and adolescence with sodium valproate (Epilim). dev Med Child Neurol 19, 9–25.
39. ↵
    1. Jan MM

    (2007) Potentially serious Lamotrigine-related skin rash. Neurosciences (Riyadh) 12, 17–20.
40. ↵
    1. Ng YT,
    2. Collins SD

    (2007) Clobazam. Neurotherapeutics 4, 138–144.
41. ↵
    1. Ng YT,
    2. Conry JA,
    3. Drummond R,
    4. Stolle J,
    5. Weinberg MA

    (2011) OV-1012 Study Investigators. Randomized, phase III study results of clobazam in Lennox-Gastaut syndrome. Neurology 77, 1473–1481.
42. ↵
    1. Messenheimer JA

    (1998) Rash in adult and pediatric patients treated with lamotrigine. Can J Neurol Sci 25, S14–S18.
43. ↵
    1. Schmidt D,
    2. Bourgeois B

    (2000) A risk-benefit assessment of therapies for Lennox-Gastaut syndrome. Drug Saf 22, 467–477.
44. ↵
    1. Jan MM,
    2. Baeesa SS,
    3. Shivji ZM

    (2003) Topiramate for the treatment of infants with early myoclonic encephalopathy. Neurosciences (Riyadh) 8, 110–112.
45. ↵
    1. Sachdeo RC,
    2. Glauser TA,
    3. Ritter F,
    4. Reife R,
    5. Lim P,
    6. Pledger G

    (1999) A double-blind, randomized trial of topiramate in Lennox-Gastaut syndrome. Topiramate YL Study Group. Neurology 52, 1882–1887.
46. ↵
    1. Hassan AA,
    2. Jan MM,
    3. Shaabat AO

    (2003) Topiramate for the treatment of intractable childhood epilepsy. Neurosciences (Riyadh) 8, 233–236.
47. ↵
    1. TOP-INT-51 Investigator's Group

    (2002) Topiramate monotherapy as broad-spectrum antiepileptic drug in a naturalistic clinical setting. Seizure 14, 371–380.
48. ↵
    1. Elsayed AM,
    2. Jan MM

    (2006) Levetiracetam in intractable childhood onset epilepsy. J Pediatr Neurol 4, 97–101.
49. ↵
    1. De Los Reyes EC,
    2. Sharp GB,
    3. Williams JP,
    4. Hale SE

    (2004) Levetiracetam in the treatment of Lennox-Gastaut syndrome. Pediatr Neurol 30, 254–256.
50. ↵
    1. Bialer M,
    2. Johannessen S,
    3. Kupferberg H,
    4. Levy R,
    5. Loiseau P,
    6. Perucca E

    (2001) Progress report on new antiepileptic drugs: a summary of the fifth EILAT conference. Epilepsy Res 43, 11–58.
51. ↵
    1. Wisniewski CS

    (2010) Rufinamide: a new antiepileptic medication for the treatment of seizures associated with lennox-gastaut syndrome. Ann Pharmacother 44, 658–667.
52. ↵
    1. Kluger G,
    2. Glauser T,
    3. Krauss G,
    4. Seeruthun R,
    5. Perdomo C,
    6. Arroyo S

    (2010) Adjunctive rufinamide in Lennox-Gastaut syndrome: a longterm, open-label extension study. Acta Neurol Scand 122, 202–208.
53. ↵
    1. Coppola G,
    2. Grosso S,
    3. Franzoni E,
    4. Veggiotti P,
    5. Zamponi N,
    6. Parisi P,
    7. et al.

    (2010) Rufinamide in children and adults with Lennox-Gastaut syndrome: first Italian multicenter experience. Seizure 19, 587–591.
54. ↵
    1. Gupta R,
    2. Appleton R

    (2005) Corticosteroids in the management of the paediatric epilepsies. Arch Dis Child 90, 379–384.
55. ↵
    1. Almaabdi KH,
    2. Alshehri RO,
    3. Althubiti AA,
    4. Alsharef ZH,
    5. Mulla SN,
    6. Alshaer DS,
    7. et al.

    (2014) Intravenous methylprednisolone for intractable childhood epilepsy. Pediatr Neurol 50, 334–336.
56. ↵
    1. Bahassan NA,
    2. Jan MM

    (2006) Ketogenic diet. Update and application. Neurosciences (Riyadh) 11, 235–240.
57. ↵
    1. You SJ,
    2. Kang HC,
    3. Ko TS,
    4. Kim HD,
    5. Yum MS,
    6. Hwang YS,
    7. et al.

    (2008) Comparison of corpus callosotomy and vagus nerve stimulation in children with Lennox-Gastaut syndrome. Brain Dev 30, 195–199.
58. ↵
    1. Lemmon ME,
    2. Terao NN,
    3. Ng YT,
    4. Reisig W,
    5. Rubenstein JE,
    6. Kossoff EH

    (2012) Efficacy of the ketogenic diet in Lennox-Gastaut syndrome: a retrospective review of one institution's experience and summary of the literature. Dev Med Child Neurol 54, 464–468.
59. ↵
    1. Karceski SC

    (2001) Vagus nerve stimulation and Lennox-Gastaut syndrome: A review of the literature and data from the VNS Patient Registry. CNS Spectrums 6, 766–770.
60. ↵
    1. Frost M,
    2. Gates J,
    3. Helmers SL,
    4. Wheless JW,
    5. Levisohn P,
    6. Tardo C,
    7. et al.

    (2001) Vagus nerve stimulation in children with refractory seizures associated with Lennox-Gastaut syndrome. Epilepsia 42, 1148–1152.
61. ↵
    1. You SJ,
    2. Kang HC,
    3. Ko TS,
    4. Kim HD,
    5. Yum MS,
    6. Hwang YS,
    7. et al.

    (2008) Comparison of corpus callosotomy and vagus nerve stimulation in children with Lennox-Gastaut syndrome. Brain Dev 30, 195–199.
62. ↵
    1. Grill MF,
    2. Ng YT

    (2010) Dramatic first words spoken in 2 children after vagus nerve stimulation. Semin Pediatr Neurol 17, 54–57.
63. ↵
    1. Cyberonics Inc. Physician's manual, VNS Therapy Pulse Model 102 Generator

    (2002) (Cyberonics Inc, Houston (TX)).
64. ↵
    1. Maehara T,
    2. Shimizu H

    (2001) Surgical outcome of corpus callosotomy in patients with drop attacks. Epilepsia 42, 67–71.
65. ↵
    1. Nei M,
    2. O’Connor M,
    3. Liporace J,
    4. Sperling MR

    (2006) Refractory generalized seizures: response to corpus callosotomy and vagal nerve stimulation. Epilepsia 47, 115–122.
66. ↵
    1. Blume WT,
    2. David RB,
    3. Gomez MR

    (1973) Generalized sharp and slow wave complexes. Associated clinical features and long-term follow-up. Brain 96, 289–306.
67. ↵
    1. Ferlazzo E,
    2. Nikanorova M,
    3. Italiano D,
    4. Bureau M,
    5. Dravet C,
    6. Calarese T,
    7. et al.

    (2010) Lennox-Gastaut syndrome in adulthood: clinical and EEG features. Epilepsy Res 89, 271–277.
68. ↵
    1. Chieffo D,
    2. Battaglia D,
    3. Lettori D,
    4. Del Re M,
    5. Brogna C,
    6. Dravet C,
    7. et al.

    (2011) Neuropsychological development in children with Dravet syndrome. Epilepsy Res 95, 86–93.